{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/62064-381#drug","name":"EGRIFTA WR","alternateName":"tesamorelin","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"62064-381"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA022505"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"839334d3-8c1d-4c26-9036-2ab524a6ea75"}],"activeIngredient":"","administrationRoute":["SUBCUTANEOUS"],"dosageForm":"KIT","manufacturer":{"@type":"Organization","name":"Theratechnologies Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA022505","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62064-381"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-31T19:49:05.173Z"}}